Sign in
A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, doxorubicin, and PEG-asparaginase (VPLD)
Journal article   Peer reviewed

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, doxorubicin, and PEG-asparaginase (VPLD)

Julio C Barredo, John M Goldberg, Gregory Hale, Jonathan Benjamin Gill, Bhuvana Setty, Tiffany Smith, Jae K Lee and Damon R Reed
Journal of clinical oncology, Vol.34(15_suppl), pp.10530-10530
2016-05-20

Metrics

8 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details